GNE0877 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It is being investigated for its potential to modulate specific biological pathways that are implicated in conditions such as Alzheimer's disease and Parkinson's disease. Researchers are exploring its efficacy in reducing the accumulation of toxic protein aggregates, which are a hallmark of these disorders. Additionally, GNE0877 is being studied for its neuroprotective properties, aiming to slow the progression of neuronal damage and improve cognitive function in preclinical models. Its application extends to the development of therapeutic agents that could offer new treatment options for patients suffering from these debilitating conditions.